Intratumoral Injection of Antisense VEGF Plasmid Suppresses K562 Cells Growth in Nude Mice and Increases Apoptosis of Leukemia Cells

Liu Bin,He Rui,Yang Xiaoyang,Feng Yi,Yang Renchi,Lu Shihong,Han Zhongchao

DOI: https://doi.org/10.3969/j.issn.1673-548X.2006.11.004

2006-01-01

Abstract:Objective To investigate the effect of antisense vascular endothelial growth factor (VEGF)_ 121 cDNA transfection in vivo on the growth of leukemia K562 cells in nude mice.Methods A plasmid encoding antisense VEGF_ 121 cDNA was delivered directly into a growing tumor (K562 chronic myeloid leukemia) established at 5 mm of average diameter. The mice received three injections of the pIRES2-EGFP plasmid of 50 mg given at 5-day interval. The control groups received either PBS or the pIRES2-EGFP plasmid alone. Tumor volumes were determined. The microvessel density (MVD) in tumor mass was counted by anti-CD31 immunohistochemistry staining, and the level of apoptotic cells was investigated by TUNEL staining. Results Direct,intratumoral injection of the plasmid induced transfection and expression of antisense VEGF in tumor and surrounding normal cells. Antisense VEGF transfection in vivo inhibited tumor growth. The microvessel density was significantly decreased (25.6±5.77 vs 41±3.8,P<0.05). TUNEL staining demonstrated an increase of cell apoptosis in the tumors from antisense-VEGF vector compared to those from control vector. Conclusions Direct intratomural injection of the plasmid carrying an antisense VEGF_ 121 cDNA can reduce tumor growth in transplanted nude mice, decrease tumor MVD, and increase tumor cell apoptosis.